Link to this page
Ontology of Drug Adverse Events
Last uploaded:
January 12, 2019
Jump to:
Preferred Name | Lovastatin [Chemical/Ingredient] | |
Synonyms |
|
|
ID |
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007106 |
|
code |
C24564
|
|
Display_Name |
Lovastatin
|
|
imported from | ||
label |
Lovastatin [Chemical/Ingredient]
|
|
MeSH_CUI |
M0012707
|
|
MeSH_Definition |
A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.
|
|
MeSH_DUI |
D008148
|
|
MeSH_Name |
Lovastatin
|
|
NUI |
N0000007106
|
|
prefixIRI |
NDF-RT:N0000007106
|
|
prefLabel |
Lovastatin [Chemical/Ingredient]
|
|
RxNorm_CUI |
6472
|
|
RxNorm_Name |
Lovastatin
|
|
Synonym |
6-Methylcompactin Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))- Monacolin K Mevinolin
|
|
UMLS_CUI |
C0024027
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping